| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:DRAK2-IN-16
CAS:871837-60-4
Purity:≥98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
DRAK2-IN-16 manufacturers
- DRAK2-IN-1
-
- $995.00 / 50mg
-
2024-10-28
- CAS:871837-60-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | DRAK2-IN-16 Basic information |
| Product Name: | DRAK2-IN-16 | | Synonyms: | DRAK2-IN-16;DRAK2-IN-1;Pentanamide, N-[3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-2,3-dihydro-2-oxo-1H-indol-5-yl]-;DRAK2IN1,DRAK2 IN 1,DRAK-2-IN-1 | | CAS: | 871837-60-4 | | MF: | C21H20N4O3 | | MW: | 376.41 | | EINECS: | | | Product Categories: | | | Mol File: | 871837-60-4.mol |  |
| | DRAK2-IN-16 Chemical Properties |
| Boiling point | 668.4±55.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 125 mg/mL (332.08 mM; Need ultrasonic) | | form | Solid | | pka | 8.57±0.20(Predicted) | | color | Orange to red |
| | DRAK2-IN-16 Usage And Synthesis |
| Uses | DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively.
DRAK2-IN-1 also has inbitory effect on DRAK1 (IC50=51 nM)[1]. | | References | [1] Jung ME, et al.Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.Bioorg Med Chem Lett.?2016 Jun 1;26(11):2719-23 DOI:10.1016/j.bmcl.2016.03.111 |
| | DRAK2-IN-16 Preparation Products And Raw materials |
|